The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex (Q43582607)

24 November 2017

The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex (English)

1 reference

24 November 2017

1 reference

Perry KW

1

1 reference

24 November 2017

Nisenbaum LK

2

1 reference

24 November 2017

George CA

3

1 reference

24 November 2017

Shannon HE

4

1 reference

24 November 2017

Felder CC

5

1 reference

24 November 2017

Bymaster FP

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

Biological Psychiatry

1 reference

24 November 2017

49

1 reference

24 November 2017

8

1 reference

24 November 2017

716-725

1 reference

Drug-induced changes of dopamine turnover in striatum and limbic system of the rat

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Potential role of muscarinic receptors in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Physostigmine ameliorates the delusions of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

M1 muscarinic antagonists interact with sigma recognition sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Muscarinic receptor-mediated induction of Fos protein in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Organization of catecholamine neurons projecting to the frontal cortex in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effects of olanzapine on regional C-Fos expression in rat forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Sequence and significance of dopamine metabolism in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

10.1016/S0006-3223(00)01017-9

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference